SEARCH

SEARCH BY CITATION

References

  • Allan, D.S., Keeney, M., Howson-Jan, K., Popma, J., Weir, K., Bhatia, M., Sutherland, D.R. & Chin-Yee, I.H. (2002) Number of viable CD34 (+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplantation, 29, 967972.
  • Ballester, O.F., Tummala, R., Janssen, W.E., Fields, K.K., Hiemenz, J.W., Goldstein, S.C., Perkins, J.B., Sullivan, D.M., Rosen, R., Sackstein, R., Zorsky, P., Saez, R. & Elfenbein, G.J. (1997) High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency. Bone Marrow Transplantation, 20, 653656.
  • Bender, J.G., To, L.B., Williams, S. & Schwartzberg, L.S. (1992) Defining a therapeutic dose of peripheral blood stem cells. Journal of Hematotherapy, 1, 329341.
  • Bensinger, W.I., Buckner, C.D., Demirer, T., Storb, R. & Appelbaum, F.A. (1996) Transplantation of allogeneic peripheral blood stem cells. Bone Marrow Transplantation, 17, S56S57.
  • De Boer, F., Drager, A.M., Pinedo, H.M., Kessler, F.L., Van Der Wall, E., Jonkhoff, A.R., Van Der Lelie, J., Huijgens, P.C., Ossenkoppele, G.J. & Schuurhuis, G.J. (2002) Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplantation, 29, 249255.
  • Champlin, R.E., Passweg, J.R., Zhang, M.J., Rowlings, P.A., Pelz, C.J., Atkinson, K.A., Barrett, A.J., Cahn, J.Y., Drobyski, W.R., Gale, R.P., Goldman, J.M., Gratwohl, A., Gordon-Smith, E.C., Henslee-Downey, P.J., Herzig, R.H., Klein, J.P., Marmont, A.M., O'Reilly, R.J., Ringden, O., Slavin, S., Sobocinski, K.A., Speck, B., Weiner, R.S. & Horowitz, M.M. (2000) T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood, 95, 39964003.
  • Chin-Yee, I., Anderson, L., Keeney, M. & Sutherland, D.R. (1997) Quality assurance of stem cell enumeration by flow cytometry. Canadian QASE Study Group. Cytometry, 30, 296303.
  • Colvin, O. (1999) Pharmacologic purging of bone marrow. In: Hematopoietic Cell Transplantation (ed. by S.Forman), pp. 217224. Blackwell Science, Inc., Malden, MA.
  • Cornelissen, J.J. & Lowenberg, B. (2000) Developments in T-cell depletion of allogeneic stem cell grafts. Current Opinions in Hematology, 7, 348352.
  • Elfenbein, G.J., Janssen, W.E. & Perkins, J.B. (1995) Relative contributions of marrow microenvironment, growth factors, and stem cells to hematopoiesis in vivo in man. Review of results from autologous stem cell transplant trials and laboratory studies at the Moffitt Cancer Center. Annals of the New York Academy of Science, 770, 315338.
  • Elwood, N.J. & Smith, C.A. (2001) Current status of retroviral vector mediated gene transfer into human hematopoietic stem cells. Leukemia and Lymphoma, 41, 118.
  • Emerson, S. (1996) Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: The next generation of cellular therapeutics. Blood, 87, 30823088.
  • Fields, K.K., Agaliotis, D.P., Janssen, W.E., Perkins, J.B., Ballester, O.F., Hiemenz, J.W., Zorsky, P.E. & Elfenbein, G.J. (1994) High-dose chemotherapy and the treatment of metastatic breast cancer. Selecting the regimen and the source of stem cells. Cancer Control, 1, 213218.
  • Fujisaki, T., Berger, M.G., Rose-John, S. & Eaves, C.J. (1999) Rapid differentiation of a rare subset of adult human lin (−) CD34 (−) CD38 (−) cells stimulated by multiple growth factors in vitro. Blood, 94, 19261932.
  • Gallacher, L., Murdoch, B., Wu, D.M., Karanu, F.N., Keeney, M. & Bhatia, M. (2000) Isolation and characterization of human CD34 (−) Lin (−) and CD34 (+) Lin (−) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood, 95, 28132820.
  • Goodell, M.A., Rosenzweig, M., Kim, H., Marks, D.F., DeMaria, M., Paradis, G., Grupp, S.A., Sieff, C.A., Mulligan, R.C. & Johnson, R.P. (1997) Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nature Medicine, 3, 13371345.
  • Gratama, J.W., Orfao, A., Barnett, D., Brando, B., Huber, A., Janossy, G., Johnsen, H.E., Keeney, M., Marti, G.E., Preijers, F., Rothe, G., Serke, S., Sutherland, D.R., Van der Schoot, C.E., Schmitz, G. & Papa, S. (1998) Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry, 34, 128142.
  • Gunji, Y., Nakamura, M., Osawa, H., Nagayoshi, K., Nakauchi, H., Miura, Y., Yanagisawa, M. & Suda, T. (1993) Human primitive hematopoietic progenitor cells are more enriched in KITlow cells than in KIThigh cells. Blood, 82, 32833289.
  • Johnsen, H.E., Baech, J. & Nikolajsen, K. (1999) Validation of the Nordic flow cytometry standard for CD34+ cell enumeration in blood and autografts: report from the third workshop. Nordic Stem Cell Laboratory Group. Journal of Hematotherapy, 8, 1528.
  • Jones, R.J., Zuehlsdorf, M., Rowley, S.D., Hilton, J., Santos, G.W., Sensenbrenner, L.L. & Colvin, O.M. (1987) Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantation. Blood, 70, 14901494.
  • Jones, R.J., Barber, J.P., Vala, M.S., Collector, M.I., Kaufmann, S.H., Ludeman, S.M., Colvin, O.M. & Hilton, J. (1995) Assessment of aldehyde dehydrogenase in viable cells. Blood, 85, 27422746.
  • Jones, R.J., Collector, M.I., Barber, J.P., Vala, M.S., Fackler, M.J., May, W.S., Griffin, C.A., Hawkins, A.L., Zehnbauer, B.A., Hilton, J., Colvin, O.M. & Sharkis, S.J. (1996) Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood, 88, 487491.
  • Kastan, M.B., Schlaffer, E., Russo, J.E., Colvin, O.M., Civin, C.I. & Hilton, J. (1990) Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood, 75, 19471950.
  • Keeney, M., Chin-Yee, I., Weir, K., Popma, J., Nayar, R. & Sutherland, D.R. (1998) Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry, 34, 6170.
  • Kohn, F.R. & Sladek, N.E. (1985) Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines. Biochemistry and Pharmacology, 34, 34653471.
  • Lagasse, E., Connors, H., Al-Dhalimy, M., Reitsma, M., Dohse, M., Osborne, L., Wang, X., Finegold, M., Weissman, I.L. & Grompe, M. (2000) Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nature Medicine, 6, 12291234.
  • Macey, M.G., McCarthy, D.A., Van Agthoven, A. & Newland, A.C. (1997) How should CD34+ cells be analysed? A study of three classes of antibody and five leucocyte preparation procedures. Journal of Immunological Methods, 204, 175188.
  • McNiece, I. (2000) The CD34+Thy1+ cell population: are they all stem cells? Experimental Hematology, 28, 13121314.
  • McNiece, I., Kern, B., Zilm, K., Brunaud, C., Dziem, G. & Briddell, R. (1998) Minimization of CD34+ cell enumeration variability using the ProCOUNT standardized methodology. Journal of Hematotherapy, 7, 499504.
  • Mahmoud, M.I., Potter, J.J., Colvin, O.M., Hilton, J. & Mezey, E. (1993) Effect of 4-(diethylamino) benzaldehyde on ethanol metabolism in mice. Alcohol Clinical and Experimental Research, 17, 12231227.
  • Mayani, H. & Lansdorp, P.M. (1994) Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood, 83, 24102417.
  • Negrin, R.S., Atkinson, K., Leemhuis, T., Hanania, E., Juttner, C., Tierney, K., Hu, W.W., Johnston, L.J., Shizurn, J.A., Stockerl-Goldstein, K.E., Blume, K.G., Weissman, I.L., Bower, S., Baynes, R., Dansey, R., Karanes, C., Peters, W. & Klein, J. (2000) Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biological Blood Marrow Transplantation, 6, 262271.
  • Niederreither, K., Subbarayan, V., Dolle, P. & Chambon, P. (1999) Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nature Genetics, 21, 444448.
  • O'Reilly, R.J. (1992) T-cell depletion and allogeneic bone marrow transplantation. Seminars in Hematology, 29, 2026.
  • Olivero, S., Alario, T., Ladaique, P., Haccoun, M., Viens, P., Blaise, D. & Chabannon, C. (1999) CD34+ cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol. Bone Marrow Transplantation, 23, 387394.
  • Reyes, M., Lund, T., Lenvik, T., Aguiar, D., Koodie, L. & Verfaillie, C.M. (2001) Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood, 98, 26152625.
  • Russo, J., Hilton, J. & Colvin, O. (1989) The role of aldehyde dehydrogenase isozymes in cellular resistance to the alklating agent cyclophosphamide. In: Enyzmology and Molecular Biology of Carbonyl Metabolism (ed. by H.Weiner & T.Flynn), p. 65. Liss, New York, NY.
  • Sahovic, E., Colvin, M., Hilton, J. & Ogawa, M. (1988) Role for aldehyde dehydrogenase in survival of progenitors for murine blast cell colonies after treatment with 4-hydroxyperoxycyclophosphamide in vitro. Cancer Research, 48, 12231226.
  • Schuurhuis, G.J., Muijen, M.M., Oberink, J.W., De Boer, F., Ossenkoppele, G.J. & Broxterman, H.J. (2001) Large populations of non-clonogenic early apoptotic CD34-positive cells are present in frozen-thawed peripheral blood stem cell transplants. Bone Marrow Transplantation, 27, 487498.
  • Serke, S. & Johnsen, H.E. (2001) A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts. Bone Marrow Transplantation, 27, 463470.
  • Sezer, O., Possinger, K., Metzner, B., Illiger, H.J., Wattad, M., Heit, W., Fuss, H. & Schultze, W. (2000) Optimal CD34 (+) cell dose in autologous peripheral-blood stem-cell transplantation. Journal of Clinical Oncology, 18, 33193320.
  • Shi, Q., Rafii, S., Wu, M.H. & Wijelath, E.S., Yu, C., Ishida, A., Fujita, Y., Kothari, S., Mohle, R., Sauvage, L.R., Moore, M.A., Storb, R.F. & Hammond, W.P. (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood, 92, 362367.
  • Shih, C.C., Weng, Y., Mamelak, A., LeBon, T., Hu, M.C. & Forman, S.J. (2001) Identification of a candidate human neurohematopoietic stem-cell population. Blood, 98, 24122422.
  • Siena, S., Schiavo, R., Pedrazzoli, P. & Carlo-Stella, C. (2000) Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. Journal of Clinical Oncology, 18, 13601377.
  • Simmons, P.J., Aylett, G.W., Niutta, S., To, L.B., Juttner, C.A. & Ashman, L.K. (1994) c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture. Experimental Hematology, 22, 157165.
  • Smith, C. & Storms, B. (2000) Hematopoietic stem cells. Clinical Orthoptics, 379s, 9197.
  • Storms, R.W., Goodell, M.A., Fisher, A., Mulligan, R.C. & Smith, C. (2000) Hoechst dye efflux reveals a novel CD7 (+) CD34 (−) lymphoid progenitor in human umbilical cord blood. Blood, 96, 21252133.
  • Storms, R.W., Trujillo, A.P., Springer, J.B., Shah, L., Colvin, O.M., Ludeman, S.M. & Smith, C. (1999) Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proceedings of the National Academy of Sciences of the United States of America, 96, 91189123.
  • Sutherland, D.R., Anderson, L., Keeney, M., Nayar, R. & Chin-Yee, I. (1996) The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. Journal of Hematotherapy, 5, 213226.
  • Thomas, E., Blume, K. & Forman, S. (eds.) (1999) Hematopoietic Cell Transplantation. Blackwell Science, Inc, Oxford, UK.
  • Udomsakdi, C., Lansdorp, P.M., Hogge, D.E., Reid, D.S., Eaves, A.C. & Eaves, C.J. (1992) Characterization of primitive hematopoietic cells in normal human peripheral blood. Blood, 80, 25132521.
  • Yin, A.H., Miraglia, S., Zanjani, E.D., Almeida-Porada, G., Ogawa, M., Leary, A.G., Olweus, J., Kearney, J. & Buck, D.W. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 90, 50025012.
  • Zambelli, A., Poggi, G., Da Prada, G., Pedrazzoli, P., Cuomo, A., Miotti, D., Perotti, C., Preti, P. & Robustelli della Cuna, G. (1998) Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Research, 18, 47054708.